A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -0.51% this year. Over the last six months, there has been a stronger performance of -32.05%. The price of MAIA fallen by 5.91% during the last 30 days period. For the last 5-days stocks have improved 3.68%.
MAIA Biotechnology Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $5.99 on 06/03/24, while the lowest value for the same period was recorded at $1.24 on 02/29/24.
52-week price history of MAIA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. MAIA Biotechnology Inc’s current trading price is -67.11% away from its 52-week high, while its distance from the 52-week low is 58.87%. The stock’s price range during this period has varied between$1.24 and $5.99. The MAIA Biotechnology Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.78 million for the day, a figure considerably higher than their average daily volume of 0.31 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
MAIA Biotechnology Inc (MAIA) has experienced a quarterly decline of -5.29% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 49.90M and boasts a workforce of 13 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.2266, with a change in price of -0.7100. Similarly, MAIA Biotechnology Inc recorded 247,853 in trading volume during the last 100 days, posting a change of -26.49%.
MAIA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MAIA stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
MAIA Stock Stochastic Average
As of today, MAIA Biotechnology Inc’s raw stochastic average for the last 50 days stands at 28.26%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 44.07%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 23.73% and 16.95%, respectively.
